Specialist investor incubating and accelerating development of innovative biotech companies

ITH is a biotech investment company located at Karolinska Institutet and the Karolinska University Hospital dedicated to innovating the next generation of personalized therapeutics and diagnostics for patients with immune related diseases.

The company’s holding structure is organized to facilitate flexible and independent development of multiple innovations in parallel while maintaining synergies throughout the R&D portfolio with shared common services and expertise.

Investors & Grants

Team

Hans Glise

Chairman

Hans Glise

Chairman

Hans Glise MD, PhD has a professorship in surgery, vast experience of clinical research both from the clinical side and as Head of Clinical research in several Therapy Areas in Astra Zeneca, Novo Nordisk and UCB. Dr Glise also was the drivning force behind the creation of SCUR, a clinical research group of 30 clinics in medicine and Surgery in Sweden, Norway and Finland.

Ahsan Amjad

Managing Director & CEO

Ahsan Amjad

Managing Director & CEO

Ahsan is a health-tech entrepreneur and investor specialising in digital health and immunotherapy. In addition to his role at ITH, Ahsan is co-Founder/Chairman at Accelerated Innovation and Managing Director at TLA, and has been an investor and Board member at several digital health companies such as Geras Solutions, KRY, HerCare, ImagineCare, and ABC Labs.

Ola Winqvist

Chief Scientific Officer

Ola Winqvist

Chief Scientific Officer

Ola is a Senior Consultant in Clinical Immunology at Karolinska University Hospital and co-founder of several biotech companies based on his inventions. Previously, Ola was a Professor of Cellular Immunotherapy and Head of Translational Immunology at the Karolinska Institutet.

Martin Hyllienmark

Chief Operating Officer

Martin Hyllienmark

Chief Operating Officer

Martin holds a double B.Sc degree from Stockholm University and University of Greenwich, UK. Martin has been working with TLA since 2015.

Stefan Warin

Board Member and Advisor

Stefan Warin

Board Member and Advisor

Extensive experience of managing biotechnology and pharmaceutical companies. Previously, President, CEO, and Chairman of the Board in Companies including Farmos Group, Ferring and Nordic Group.

Jonas Winqvist

Board Member and Advisor

Jonas Winqvist

Board Member and Advisor

Experience in strategy consulting and finance. Partner at Implement Consulting Group. Previosly, Vice President at CapGemini, and Auditor at E&Y.

Contact

ITH, Immune Therapy Holdings AB
Nanna Svartz Väg 2
171 65 Solna
Sweden

martin.hyllienmark@ithgroup.se

Google map